Skip to main content

Advertisement

SpringerLink
Log in

Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Objective

To assess the relationship between pre- and postoperative high-risk human papillomavirus (hrHPV) genotypes and hrHPV type-specific persistence and reappearance of abnormal cytology after successful conization.

Methods

A retrospective analysis was performed of 211 patients who were undergoing conization after hrHPV genotype testing at Tottori University Hospital between July 2009 and June 2013. Of the 211 women, 129 underwent pre- and postoperative hrHPV genotype testing and were diagnosed with cervical intraepithelial neoplasia (CIN) grades 1–3 with negative margins.

Results

The postoperative pathological diagnosis was CIN 1 in 8 patients, CIN 2 in 12, CIN 3 in 108 and adenocarcinoma in situ in 1 patient. Before conization, the most frequent hrHPV genotypes were HPV16 (n = 52; 40.3 %), followed by HPV52 (n = 32; 24.8 %) and HPV58 (n = 28; 21.7 %), while HPV18 was detected in 6 cases (4.7 %). Of the 23 postoperative hrHPV-positive cases, the same genotypes were detected in 10 cases while a different genotype was detected in 11 cases; type did not affect the frequency of persistent postoperative infection. The 3-year cumulative risk for the reappearance of abnormal cytology was significantly higher in postoperative hrHPV-positive patients than in postoperative hrHPV-negative patients (31.6 vs 9.7 %, P = 0.0014). A high-grade squamous intraepithelial lesion (HSIL) was observed during the follow-up period in one patient with persistent HPV16 infection.

Conclusions

Postoperative hrHPV infection was a significant positive predictor for the reappearance of abnormal cytology and HPV16 infection-induced HSIL after treatment. Therefore, our study suggests that hrHPV genotype testing may be useful to follow-up CIN patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. American Cancer Society (2015) Global cancer facts & Figures 3rd edn. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-044738.pdf

  2. Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12:186–192

    Article  CAS  PubMed  Google Scholar 

  3. Pinto AP, Crum CP (2000) Natural history of cervical neoplasia: defining progression and its consequence. Clin Obstet Gynecol 43:352–362

    Article  CAS  PubMed  Google Scholar 

  4. Bouvard V, Baan R, Straif K et al (2009) A review of human carcinogens—Part B: biological agents. Lancet Oncol 10:321–322

    Article  PubMed  Google Scholar 

  5. Massad LS, Einstein MH, Huh WK et al (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 121:829–846

    Article  PubMed  Google Scholar 

  6. Gonzalez DI Jr, Zahn CM, Retzloff MG et al (2001) Recurrence of dysplasia after loop electrosurgical excision procedures with long-term follow-up. Am J Obstet Gynecol 184:315–321

    Article  PubMed  Google Scholar 

  7. Zielinski GD, Bais AG, Helmerhorst TJ et al (2004) HPV testing and monitoring of women after treatment of CIN3: review of the literature and meta-analysis. Obstet Gynecol Surv 59:543–553

    Article  CAS  PubMed  Google Scholar 

  8. Kocken M, Helmerhorst TJ, Berkhof J et al (2011) Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. Lancet Oncol 12:441–450

    Article  PubMed  Google Scholar 

  9. Chao A, Lin CT, Hsueh S et al (2004) Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 190:1046–1051

    Article  PubMed  Google Scholar 

  10. Kocken M, Uijterwaal MH, de Vries AL et al (2012) High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis. Gynecol Oncol 125:500–507

    Article  PubMed  Google Scholar 

  11. Gosvig CF, Huusom LD, Andersen KK et al (2013) Persistence and reappearance of high-risk human papillomavirus after conization. Gynecol Oncol 131:661–666

    Article  PubMed  Google Scholar 

  12. Nagai Y, Maehama T, Asato T et al (2000) Persistence of human papillomavirus infection after therapeutic conization for CIN3: is it an alarm for disease recurrence? Gynecol Oncol 79:294–299

    Article  CAS  PubMed  Google Scholar 

  13. Lubrano A, Medina N, Benito V et al (2012) Follow-up after LLETZ: a study of 682 cases of CIN2–CIN3 in a single institution. Eur J Obstet Gynecol Reprod Biol 161:71–74

    Article  PubMed  Google Scholar 

  14. Soderlund-Strand A, Kjellberg L, Dillner J (2014) Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia. J Med Virol 86:634–641

    Article  PubMed  Google Scholar 

  15. Kim YT, Lee JM, Hur SY et al (2010) Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Int J Cancer 126:1903–1909

    CAS  PubMed  Google Scholar 

  16. Kucera E, Sliutz G, Czerwenka K et al (2001) Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone? Eur J Obstet Gynecol Reprod Biol 100:72–76

    Article  CAS  PubMed  Google Scholar 

  17. Costa S, De Simone P, Venturoli S et al (2003) Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 90:358–365

    Article  PubMed  Google Scholar 

  18. Zielinski GD, Rozendaal L, Voorhorst FJ et al (2003) HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3. Gynecol Oncol 91:67–73

    Article  PubMed  Google Scholar 

  19. Cecchini S, Carozzi F, Confortini M et al (2004) Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure. Tumori 90:225–228

    PubMed  Google Scholar 

  20. Sarian LO, Derchain SF, Andrade LA et al (2004) HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia. Gynecol Oncol 94:181–186

    Article  PubMed  Google Scholar 

  21. Alonso I, Torne A, Puig-Tintore LM et al (2006) Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN2–3. Gynecol Oncol 103:631–636

    Article  PubMed  Google Scholar 

  22. Kreimer AR, Guido RS, Solomon D et al (2006) Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiol Biomark Prev 15:908–914

    Article  Google Scholar 

  23. Kreimer AR, Katki HA, Schiffman M et al (2007) Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3. Cancer Epidemiol Biomark Prev 16:11–16

    Article  Google Scholar 

  24. Smart OC, Sykes P, Macnab H et al (2010) Testing for high risk human papilloma virus in the initial follow-up of women treated for high-grade squamous intraepithelial lesions. Aust N Z J Obstet Gynaecol 50:164–167

    Article  PubMed  Google Scholar 

  25. Jones J, Saleem A, Rai N et al (2011) Human Papillomavirus genotype testing combined with cytology as a ‘test of cure’ post treatment: the importance of a persistent viral infection. J Clin Virol 52:88–92

    Article  PubMed  Google Scholar 

  26. Song SH, Lee JK, Oh MJ et al (2006) Persistent HPV infection after conization in patients with negative margins. Gynecol Oncol 101:418–422

    Article  PubMed  Google Scholar 

  27. Heymans J, Benoy IH, Poppe W et al (2011) Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation. Int J Cancer 129:903–909

    Article  CAS  PubMed  Google Scholar 

  28. Kong TW, Son JH, Chang SJ et al (2014) Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix. Gynecol Oncol 135:468–473

    Article  PubMed  Google Scholar 

  29. McCredie MR, Sharples KJ, Paul C et al (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9:425–434

    Article  PubMed  Google Scholar 

  30. Kreimer AR, Schiffman M, Herrero R et al (2012) Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment. Int J Cancer 131:211–218

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Depertment of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishicho, Yonago-City, Tottori, 683-8504, Japan

    Akiko Kudoh, Shinya Sato, Hiroaki Itamochi, Hiroaki Komatsu, Michiko Nonaka, Seiya Sato, Jun Chikumi, Muneaki Shimada, Tetsuro Oishi & Tasuku Harada

  2. Depertment of Obstetrics and Gynecology, Iwate Medical University School of Medicine, 19-1 Uchimaru, Morioka-City, Iwate, 020-8505, Japan

    Hiroaki Itamochi & Seiya Sato

  3. Matsue City Hospital, 32-1 Noshira, Matsue-City, Shimane, 690-8509, Japan

    Junzo Kigawa

Authors
  1. Akiko Kudoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shinya Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroaki Itamochi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroaki Komatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michiko Nonaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seiya Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jun Chikumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Muneaki Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tetsuro Oishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Junzo Kigawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tasuku Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroaki Itamochi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kudoh, A., Sato, S., Itamochi, H. et al. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia. Int J Clin Oncol 21, 580–587 (2016). https://doi.org/10.1007/s10147-015-0929-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-015-0929-x

Keywords

Search

Navigation